Please try another search
The objective of the Sub-Fund is to generate a consistent total return above the return generated by traditional investment vehicles through investments in long/short equity strategies. To achieve the investment objective, the Sub-Fund will invest in a global portfolio of equities, equity related derivatives, equity index derivatives and other equity related instruments, including but not limited to swaps, convertibles and ETFs, with focus on the healthcare industry.
Name | Title | Since | Until |
---|---|---|---|
Henrik Rhenman | Senior Portfolio Manager | 2009 | Now |
Biography | Over 20 years of portfolio management experience 1999 – 2008 Founder and Chief Investment Officer, Carnegie Healthcare Funds, Carnegie Investment Bank 1997 – 1999 Managing Director, Portfolio Manager, SG Cowen, Boston 1991 – 1997 Portfolio Manager, SEB Pharmaceutical Fund 1988 – 1991 Head of Research, Head of Asset Management, Hagströmer & Qviberg 1978 – 1988 Pharmacia, Alfa-Laval |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review